Squarepoint Ops LLC bought a new position in Maximus, Inc. (NYSE:MMS - Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 303,567 shares of the health services provider's stock, valued at approximately $22,661,000. Squarepoint Ops LLC owned 0.53% of Maximus as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Norges Bank acquired a new stake in Maximus during the 4th quarter worth $71,443,000. SG Capital Management LLC acquired a new stake in shares of Maximus during the fourth quarter worth about $30,285,000. Federated Hermes Inc. lifted its holdings in shares of Maximus by 74.8% during the 4th quarter. Federated Hermes Inc. now owns 882,953 shares of the health services provider's stock valued at $65,912,000 after purchasing an additional 377,705 shares in the last quarter. AQR Capital Management LLC lifted its holdings in shares of Maximus by 189.1% during the 4th quarter. AQR Capital Management LLC now owns 423,298 shares of the health services provider's stock valued at $31,599,000 after purchasing an additional 276,859 shares in the last quarter. Finally, Marshall Wace LLP grew its position in shares of Maximus by 1,319.1% in the 4th quarter. Marshall Wace LLP now owns 224,267 shares of the health services provider's stock valued at $16,742,000 after purchasing an additional 208,463 shares during the period. 97.21% of the stock is owned by institutional investors.
Insider Activity
In related news, Director Jan Madsen sold 2,439 shares of the company's stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the sale, the director now owns 18,097 shares in the company, valued at approximately $1,225,347.87. This represents a 11.88% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 1.60% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen downgraded shares of Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th.
Check Out Our Latest Report on Maximus
Maximus Stock Down 1.8%
NYSE MMS traded down $1.33 on Friday, reaching $72.36. The company had a trading volume of 456,402 shares, compared to its average volume of 561,243. The company's fifty day moving average is $69.37 and its 200-day moving average is $72.29. The firm has a market capitalization of $4.08 billion, a price-to-earnings ratio of 15.56 and a beta of 0.61. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.97.
Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The health services provider reported $2.01 EPS for the quarter, beating analysts' consensus estimates of $1.37 by $0.64. The company had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.29 billion. Maximus had a return on equity of 21.95% and a net margin of 5.28%. The company's quarterly revenue was up 1.0% compared to the same quarter last year. During the same period in the previous year, the company posted $1.57 earnings per share. On average, research analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.
Maximus Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Saturday, May 31st. Stockholders of record on Thursday, May 15th will be paid a dividend of $0.30 per share. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.66%. Maximus's dividend payout ratio is currently 23.86%.
Maximus Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Further Reading

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.